Obinutuzumab Intravenous and Omeprazole Delayed-Release Capsules and Tablets (OTC)
Determining the interaction of Obinutuzumab Intravenous and Omeprazole Delayed-Release Capsules and Tablets (OTC) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: obinutuzumab
Brand name: Gazyva
Synonyms: Obinutuzumab
Generic Name: omeprazole
Brand name: FIRST Omeprazole, Omeprazole + SyrSpend SF Alka, Prilosec, Prilosec OTC, Zegerid>, Prilosec, Prilosec OTC
Synonyms: Omeprazole
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Obinutuzumab Intravenous-Omeprazole Orally-Disintegrating Tablets
- Obinutuzumab Intravenous-Omeprazole Powder for Oral Suspension
- Obinutuzumab Intravenous-Omeprazole Tablets
- Obinutuzumab Intravenous-Omeprazole, Clarithromycin, and Amoxicillin
- Obinutuzumab Intravenous-Omidria
- Obinutuzumab Intravenous-Omidria Ophthalmic
- Omeprazole Delayed-Release Capsules and Tablets (OTC)-Obizur
- Omeprazole Delayed-Release Capsules and Tablets (OTC)-Obizur Intravenous
- Omeprazole Delayed-Release Capsules and Tablets (OTC)-Obredon
- Omeprazole Delayed-Release Capsules and Tablets (OTC)-Ocaliva
- Omeprazole Delayed-Release Capsules and Tablets (OTC)-Occlucort
- Omeprazole Delayed-Release Capsules and Tablets (OTC)-Occlusal-HP Topical